Eledon Pharmaceuticals, Inc.
ELDN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001404281
No open-market purchases or sales by Eledon Pharmaceuticals, Inc. insiders were filed in the last 90 days; 161 institutions reported holding it in 13F filings for Q2 2026, worth $184.6M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Eledon Pharmaceuticals, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 85
- +2 vs. Q1 2025
- Shares held
- 40.8M
- +2.39M (+6.2%) vs. Q1 2025
- Total value
- $110.7M
- −$19.7M (−15.1%) vs. Q1 2025
- New holders
- 28
- 21 more added
- Sold out
- 26
- 15 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ELDN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 161 | $184.6M |
| Q1 2026 | 121 | $131.2M |
| Q4 2025 | 95 | $66.7M |
| Q3 2025 | 83 | $94.5M |
| Q2 2025 | 85 | $110.7M |
| Q1 2025 | 83 | $130.3M |
| Q4 2024 | 75 | $158.5M |
| Q3 2024 | 33 | $46.0M |
| Q2 2024 | 32 | $48.2M |
| Q1 2024 | 29 | $19.8M |
| Q4 2023 | 29 | $16.5M |
| Q3 2023 | 28 | $12.2M |
| Q2 2023 | 33 | $12.7M |
| Q1 2023 | 30 | $14.7M |
| Q4 2022 | 28 | $14.4M |
| Q3 2022 | 31 | $17.3M |
| Q2 2022 | 31 | $15.9M |
| Q1 2022 | 32 | $27.6M |
| Q4 2021 | 36 | $34.7M |
| Q3 2021 | 35 | $52.1M |
| Q2 2021 | 34 | $74.5M |
| Q1 2021 | 34 | $89.0M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Eledon Pharmaceuticals, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −15,089−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −13,620−100.0% | Sold out |
| Capstone Investment Advisors, LLC | 0 | $0 | 0.00% | −13,613−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −12,080−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −12,065−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −10,866−100.0% | Sold out |
| Capula Management Ltd | 0 | $0 | 0.00% | −10,170−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −1,782−100.0% | Sold out |
| Jones Financial Companies LLLP | 0 | $0 | 0.00% | −725−100.0% | Sold out |
| N.E.W. Advisory Services LLC | 0 | $0 | 0.00% | −626−100.0% | Sold out |
| Insight Financial Services | 0 | $0 | 0.00% | −100−100.0% | Sold out |